Should SGLT2 inhibitors be part of standard of care for patients with insufficiently controlled type 2 diabetes

Join to view this video!

On demand, watch anytime, anywhere.

Free diabetes education for HCPs.

Login
Signup
© 2021 CloserStill Media.
Terms & Conditions Privacy Policy